Insider Selling: Trupanion (NASDAQ:TRUP) Director Sells $223,630.77 in Stock

Trupanion, Inc. (NASDAQ:TRUP) Director Murray Low sold 6,537 shares of Trupanion stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $34.21, for a total transaction of $223,630.77. Following the completion of the sale, the director owned 147,997 shares of the company’s stock, valued at $5,062,977.37. This trade represents a 4.23% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Trupanion Stock Performance

NASDAQ TRUP traded up $0.18 during trading on Friday, reaching $34.48. The company’s stock had a trading volume of 239,749 shares, compared to its average volume of 457,454. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.24. The firm has a market capitalization of $1.49 billion, a price-to-earnings ratio of 56.52, a price-to-earnings-growth ratio of 1.58 and a beta of 1.27. Trupanion, Inc. has a 12 month low of $21.16 and a 12 month high of $38.98. The firm has a 50 day moving average price of $27.72 and a 200 day moving average price of $26.75.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Thursday, November 5th. The financial services provider reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.04. Trupanion had a net margin of 1.71% and a return on equity of 6.71%. The firm had revenue of $405.59 million for the quarter, compared to analyst estimates of $402.53 million. During the same quarter in the prior year, the business posted $0.13 EPS. As a group, equities analysts anticipate that Trupanion, Inc. will post 0.68 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on TRUP. Piper Sandler cut Trupanion from an “overweight” rating to a “neutral” rating and cut their price target for the company from $45.00 to $32.00 in a research note on Wednesday, August 26th. Stifel Nicolaus increased their target price on Trupanion from $29.00 to $34.00 and gave the stock a “hold” rating in a report on Monday, November 9th. Cantor Fitzgerald raised their price target on Trupanion from $30.00 to $33.00 and gave the stock a “neutral” rating in a research report on Monday, November 9th. Wall Street Zen raised Trupanion from a “hold” rating to a “buy” rating in a research note on Saturday, November 7th. Finally, Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 24th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, Trupanion currently has an average rating of “Hold” and an average target price of $40.00.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in TRUP. Bank of New York Mellon Corp bought a new position in shares of Trupanion in the second quarter worth about $4,631,000. Bank of America Corp DE acquired a new stake in shares of Trupanion in the 2nd quarter valued at approximately $14,262,000. Renaissancere Holdings Ltd. bought a new stake in shares of Trupanion during the 2nd quarter valued at approximately $6,514,510. Legal & General Group Plc bought a new stake in shares of Trupanion during the 2nd quarter valued at approximately $1,938,000. Finally, GSA Capital Partners LLP bought a new stake in shares of Trupanion during the 2nd quarter valued at approximately $1,394,000.

About Trupanion

Trupanion provides medical insurance for cats and dogs, offering coverage for eligible veterinary care. Its products are designed to help pet owners manage unexpected costs from illnesses and injuries, subject to policy terms and exclusions. The company also provides software and payment services that enable participating veterinary practices to submit claims and receive payments directly, reducing the need for customers to pay covered costs upfront and seek reimbursement. Founded in 2000 and headquartered in Seattle, Trupanion serves customers in the United States and Canada.